Homeodomain-Interacting Protein Kinase 2 (HIPK2): A Promising Target for Anti-Cancer Therapies

Oncotarget - United States
doi 10.18632/oncotarget.14723
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Homeodomain-Interacting Protein Kinase-2 (HIPK2) Phosphorylates HMGA1a at Ser-35, THR-52, and THR-77 and Modulates Its DNA Binding Affinity

Journal of Proteome Research
BiochemistryChemistry
2007English

Homeodomain-Interacting Protein Kinase Regulates Hippo Pathway-Dependent Tissue Growth

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2012English

Centrosome &Ndash; A Promising Anti-Cancer Target

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2016English

The 26S Proteasome Is a Multifaceted Target for Anti-Cancer Therapies

Oncotarget
Oncology
2015English

Repression of the Antiapoptotic Molecule Galectin-3 by Homeodomain-Interacting Protein Kinase 2-Activated P53 Is Required for P53-Induced Apoptosis

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2006English

HMGB1: A Promising Therapeutic Target for Prostate Cancer

Prostate Cancer
Cancer ResearchOncologyUrology
2013English

Protein Kinase D as a Potential New Target for Cancer Therapy

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2010English

The Dual Kinase Complex FAK-Src as a Promising Therapeutic Target in Cancer

OncoTargets and Therapy
OncologyPharmacology
2010English

A-Kinase-Interacting Protein Localizes Protein Kinase a in the Nucleus

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy